Aidapak Recalls Aspirin/ER Dipyridamole Capsules Due to Labeling Error
Aidapak Services, LLC is recalling Aspirin/ER Dipyridamole capsules because they may have been mislabeled as other medications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported injuries or illnesses, fitting the criteria for a moderate severity score.
Plain-English summary
Aidapak Services, LLC is recalling Aspirin/ER Dipyridamole, Capsule, 25 mg/200 mg, NDC 00597000160. The recall is due to a labeling error where the product may have been mislabeled as Thiamine HCL, Levothyroxine Sodium, or Zinc Sulfate.
The affected repacked drugs were distributed in Arizona, California, Oregon, and Washington. Specific pedigree codes and expiration dates are listed in the recall notice for identification.
Consumers should check their medication for the specific NDC and pedigree codes listed in the official recall notice. If the medication matches the recalled product, they should stop using it and contact their pharmacist or healthcare provider for instructions on disposal or replacement.
The recalled product
- Product
- ASPIRIN/ER DIPYRIDAMOLE, Capsule, 25 mg/200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00597000160.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 300
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- ASPIRIN/ER DIPYRIDAMOLE
- Capsule
- 25 mg/200 mg has the following codes: Pedigree: AD70639_4
- EXP: 7/28/2013
- Pedigree: W003468
- EXP: 8/19/2013
- Pedigree: W003644
- EXP: 8/24/2013.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- SevereInstrumentation Laboratory Recalls HemoslL AcuStar HIT-lgG In Vitro Diagnostic Reagents
FDA (Devices) · 2026-10-21
- LowMagellan LeadCare II Blood Lead Test Kit Recall for Labeling Error
FDA (Devices) · 2026-10-21
- ModerateIn2bones Recalls Partially Threaded Bone Screws Due to Labeling Error
FDA (Devices) · 2026-10-21
- ModerateGore Viabil Short Wire Biliary Endoprosthesis Recalled for Incorrect Length Labeling
FDA (Devices) · 2026-10-21
Similar recalls
- ModeratePrednisone Tablets Recalled for Potential Label Mixup with Aspirin
FDA (Drugs) · 2014-01-22
- SevereMesalamine CR Capsules Recalled for Potential Label Mixup with Aspirin
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Aspirin EC Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Acetaminophen Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateNifedipine Capsules Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Nifedipine Capsules Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22